183 related articles for article (PubMed ID: 36420140)
1. Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells.
Ferguson KM; Blin C; Alfazema N; Gangoso E; Pollard SM; Marques-Torrejon MA
Front Cell Dev Biol; 2022; 10():983097. PubMed ID: 36420140
[TBL] [Abstract][Full Text] [Related]
2. HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
Herdenberg C; Hedman H
Stem Cell Rev Rep; 2023 Jan; 19(1):59-66. PubMed ID: 35969315
[TBL] [Abstract][Full Text] [Related]
3. LRIG1 is a gatekeeper to exit from quiescence in adult neural stem cells.
Marqués-Torrejón MÁ; Williams CAC; Southgate B; Alfazema N; Clements MP; Garcia-Diaz C; Blin C; Arranz-Emparan N; Fraser J; Gammoh N; Parrinello S; Pollard SM
Nat Commun; 2021 May; 12(1):2594. PubMed ID: 33972529
[TBL] [Abstract][Full Text] [Related]
4. Elevated FOXG1 in glioblastoma stem cells cooperates with Wnt/β-catenin to induce exit from quiescence.
Robertson FL; O'Duibhir E; Gangoso E; Bressan RB; Bulstrode H; Marqués-Torrejón MÁ; Ferguson KM; Blin C; Grant V; Alfazema N; Morrison GM; Pollard SM
Cell Rep; 2023 Jun; 42(6):112561. PubMed ID: 37243590
[TBL] [Abstract][Full Text] [Related]
5. Lrig1 expression identifies quiescent stem cells in the ventricular-subventricular zone from postnatal development to adulthood and limits their persistent hyperproliferation.
Nam HS; Capecchi MR
Neural Dev; 2023 Jan; 18(1):1. PubMed ID: 36631891
[TBL] [Abstract][Full Text] [Related]
6. Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence.
Jensen KB; Watt FM
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11958-63. PubMed ID: 16877544
[TBL] [Abstract][Full Text] [Related]
7. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
[TBL] [Abstract][Full Text] [Related]
8. LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.
Ji Y; Kumar R; Gokhale A; Chao HP; Rycaj K; Chen X; Li Q; Tang DG
Semin Cancer Biol; 2022 Jul; 82():120-133. PubMed ID: 33476721
[TBL] [Abstract][Full Text] [Related]
9. Lrig1 expression prospectively identifies stem cells in the ventricular-subventricular zone that are neurogenic throughout adult life.
Nam HS; Capecchi MR
Neural Dev; 2020 Mar; 15(1):3. PubMed ID: 32183906
[TBL] [Abstract][Full Text] [Related]
10. The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastoma.
Neirinckx V; Hau AC; Schuster A; Fritah S; Tiemann K; Klein E; Nazarov PV; Matagne A; Szpakowska M; Meyrath M; Chevigné A; Schmidt MHH; Niclou SP
Neurooncol Adv; 2019; 1(1):vdz024. PubMed ID: 32642659
[TBL] [Abstract][Full Text] [Related]
11. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
[TBL] [Abstract][Full Text] [Related]
12. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
[TBL] [Abstract][Full Text] [Related]
13. The LRIG family: enigmatic regulators of growth factor receptor signaling.
Simion C; Cedano-Prieto ME; Sweeney C
Endocr Relat Cancer; 2014; 21(6):R431-43. PubMed ID: 25183430
[TBL] [Abstract][Full Text] [Related]
14. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
15. LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.
Yang JA; Liu BH; Shao LM; Guo ZT; Yang Q; Wu LQ; Ji BW; Zhu XN; Zhang SQ; Li CJ; Chen QX
Int J Clin Exp Pathol; 2015; 8(4):3580-90. PubMed ID: 26097540
[TBL] [Abstract][Full Text] [Related]
16. In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear.
Del Rio T; Nishitani AM; Yu WM; Goodrich LV
PLoS Genet; 2013; 9(9):e1003824. PubMed ID: 24086156
[TBL] [Abstract][Full Text] [Related]
17. Redistribution of LRIG proteins in psoriasis.
Karlsson T; Mark EB; Henriksson R; Hedman H
J Invest Dermatol; 2008 May; 128(5):1192-5. PubMed ID: 18037903
[TBL] [Abstract][Full Text] [Related]
18. Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.
Mao F; Holmlund C; Faraz M; Wang W; Bergenheim T; Kvarnbrink S; Johansson M; Henriksson R; Hedman H
Oncogenesis; 2018 Feb; 7(2):13. PubMed ID: 29391393
[TBL] [Abstract][Full Text] [Related]
19. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
[TBL] [Abstract][Full Text] [Related]
20. Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture.
Marques-Torrejon MA; Gangoso E; Pollard SM
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29196443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
